Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 2-year average of 8.73%, near the low end of its 2-year range (0.00%–35.78%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
8.73%
DEBT TO ASSETS RATIO AVG 5Y
0.00%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Polyrizon Ltd.
Market Cap
$10.83M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
8.73%
5Y Avg
0.00%
Market Cap
$10.41M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.69M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.18M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.10M
Debt to Assets Ratio
0.80%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polyrizon Ltd. (PLRZ) | $10.83M | 0.00% | 0.00% | 8.73% | 0.00% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | 0.06% | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.65M | 0.32% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.69M | 0.00% | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 0.01% | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $10.94M | 0.02% | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | 0.80% | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | 0.54% | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.06M | 1.40% | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | 0.61% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
36.37
Interest Coverage
-2.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 25.77% |
| 2024-03-31 | 25.77% |
| 2023-12-31 | 35.78% |
| 2022-12-31 | 0.00% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 0.00% |
